Arylmorpholine, preparation and use

Abstract

A method for the treatment of depression in a human being, the method comprising administering to the human being an antidepressant effective amount of a compound of the following formula ##STR1## or a pharmaceutically acceptable salt thereof, wherein R and R 1 are independently hydrogen or fluorine.

We claim: 
     
       1. A method for the treatment of depression in a human being, the method comprising administering to the human being an antidepressant effective amount of a compound of the following formula ##STR6## or a pharmaceutically acceptable salt thereof, wherein R and R 1  are independently hydrogen or fluorine. 
     
     
       2. The method for treatment of depression in accord with claim 1, wherein the compound is 2-(3-fluorophenyl)-3,5-dimethylmorpholine. 
     
     
       3. The method for treatment of depression in accord with claim 1, wherein the compound is 2-(3,4-difluorophenyl)-3,5-dimethylmorpholine. 
     
     
       4. The method for treatment of depression in accord with claims 1, 2 or 3, wherein the compound or its salt is administered orally. 
     
     
       5. The method for treatment of depression in accord with claims 1, 2 or 3, wherein the compound or its salt is administered with a pharmaceutically acceptable carrier. 
     
     
       6. The method for treatment of depression in accord with claims 5, wherein the compound or its salt is administered orally. 
     
     
       7. The method for treatment of depression in accord with claim 4, wherein the compound or its salt is administered in the form of an orally ingestible capsule or tablet. 
     
     
       8. The method for treatment of depression in accord with claim 6, wherein the compound or its salt is administered in the form of an orally ingestible capsule or tablet.